Triple
T22404610
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Regulation (EU) No 536/2014 |
E553848
|
entity |
| Predicate | fullName |
P16
|
FINISHED |
| Object | Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use | Statement: [Regulation (EU) No 536/2014, fullName, Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use Context triple: [Regulation (EU) No 536/2014, fullName, Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use]
-
A.
Regulation (EU) 2017/746 on in vitro diagnostic medical devices
Regulation (EU) 2017/746 on in vitro diagnostic medical devices is the European Union’s comprehensive legal framework governing the safety, performance, and market access of in vitro diagnostic medical devices.
-
B.
Regulation (EU) No 536/2014
chosen
Regulation (EU) No 536/2014 is the European Union’s main legal framework governing the conduct, authorization, and oversight of clinical trials on medicinal products for human use.
-
C.
Regulation (EU) No 806/2014
Regulation (EU) No 806/2014 is an EU law that establishes the Single Resolution Mechanism for the orderly resolution of failing banks in the euro area, including rules for the use and governance of the Single Resolution Fund.
-
D.
Regulation (EU) No 1022/2013
Regulation (EU) No 1022/2013 is a European Union legislative act that reformed the powers of the European Banking Authority to support the establishment and functioning of the Single Supervisory Mechanism for banking supervision in the euro area.
-
E.
Regulation (EU) No 604/2013
Regulation (EU) No 604/2013 is an EU law that sets out the criteria and mechanisms for determining which Member State is responsible for examining an application for international protection lodged in the EU.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e4da7048190b4387d422a9a0de5 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f158b6762c8190991fc14c5ca8e609 |
completed | April 29, 2026, 1:02 a.m. |
Created at: April 16, 2026, 8:46 p.m.